Ph.D., whose research focus is on new therapeutic targets in GIST.
Olli-Pekka Pulkka, Ph.D. (born in 1985) is a founder and board member of the Company. He is a cell and molecular biologist who graduated from the University of Jyväskylä, Finland in 2012. His research is focused on the prognostic factors and novel therapeutic targets in GIST. Dr. Pulkka prepared his PhD thesis on the role of PDE3 as a therapy target in GIST.